Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, April 18 2014 5:03pm ET - U.S. Markets Closed.
Industry Center - Diagnostic Substances
Industry Center > Diagnostic Substances > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Diagnostic Substances News
Latest News
Friday, Apr 18, 2014
·Federal Court Grants Preliminary Approval Of Settlement In Abaxis Shareholder Lawsuit
PR Newswire - 1 hour, 3 minutes ago
Wednesday, Apr 16, 2014
·AMAG Pharmaceuticals Announces Appointment of Jim Sulat to Its Board of Directors and the Transition of Chairman Role to Gino Santini
GlobeNewswire - Wed Apr 16
·Trinity Biotech plc to Announce First Quarter Fiscal Year 2014 Financial Results
GlobeNewswire - Wed Apr 16
Tuesday, Apr 15, 2014
·Quidel to Hold First Quarter 2014 Financial Results Conference Call on April 23, 2014
Marketwire - Tue Apr 15
·IDEXX Laboratories to Release 2014 First Quarter Financial Results
PR Newswire - Tue Apr 15
·Abaxis To Report Fourth Quarter And Fiscal Year 2014 Financial Results Thursday, April 24, 2014
PR Newswire - Tue Apr 15
Thursday, Apr 10, 2014
·Meridian: A Great Dividend Find
at Seeking Alpha - Thu Apr 10
Tuesday, Apr 8, 2014
·Venaxis, Inc. Closes Public Offering of Common Shares
PR Newswire - Tue Apr 8
·Balanced View on Genomic Health
Zacks.com - Tue Apr 8
·Edwards' Intuity Elite Cleared in Europe
Zacks.com - Tue Apr 8
·Abaxis receives Health Canada Class III approval for Piccolo Xpress
- Tue Apr 8
·Abaxis Receives Health Canada Class III Approval for Piccolo Xpress®
PR Newswire - Tue Apr 8
Monday, Apr 7, 2014
·Accelerate Diagnostics Commences Rights Offering
PR Newswire - Mon Apr 7
·Chembio Terminates U.S. Distribution Agreement With Alere
GlobeNewswire - Mon Apr 7
Friday, Apr 4, 2014
·New Jobs at Baxter's Malta Facility
Zacks.com - Fri Apr 4
Thursday, Apr 3, 2014
·Why Venaxis (APPY) Stock Is Down Today
at TheStreet.com - Thu Apr 3
·Venaxis, Inc. Prices $20.0 Million Public Offering of Common Shares
PR Newswire - Thu Apr 3
Wednesday, Apr 2, 2014
·Venaxis, Inc. Announces Proposed Public Offering of Common Shares
PR Newswire - Wed Apr 2
·Ben R. Chen Joins Atossa Genetics as Senior Vice President of Global Regulatory Affairs and Quality Assurance
Marketwire - Wed Apr 2
Tuesday, Apr 1, 2014
·Covidien's Ablation System: A Sure Winner
Zacks.com - Tue Apr 1
More Latest News...
Sponsor Results
Industry News
Hoover's Official Site: Profiles on 85MM+ Companies. Expert Advice.
www.hoovers.com
Forward
Forward provides continuous passive motion therapy equipment
cpmrental.com
Medical Equipment & Parts
Need Specialty Medical, Hospital and Healthcare Equipment & Parts?
ALCOsales.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Diagnostic Substances Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?